Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|March 30, 2010
Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1Babafemi Taiwo, Charles Hicks, Joseph Eron
AIDS Patient Care and Stds|June 27, 2013
Diagnosing HIV infection in primary care settings: missed opportunitiesTammy Chin, Charles Hicks, Gregory Samsa, et al.
The American Journal of Medicine|April 3, 2007
Late diagnosis of HIV infection: the role of age and sexMichael J Mugavero, Chelsea Castellano, David Edelman, et al.
AIDS Patient Care and Stds|June 21, 2003
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complicationsCharles Hicks, Judith Currier, Paul Sax, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|July 29, 2014
"Know Your Status": results from a novel, student-run HIV testing initiative on college campusesCaitlin Milligan, C Nicholas Cuneo, Sarah E Rutstein, et al.
Biophysical Journal|June 30, 2005
Calcium ligation in photosystem II under inhibiting conditionsBridgette A Barry, Charles Hicks, Antonio De Riso, et al.
AIDS Research and Human Retroviruses|October 18, 2012
Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected personsWanda Lakey, Lan-Yan Yang, William Yancy, et al.
Open Forum Infectious Diseases|October 6, 2016
Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of DiseaseShereen Katrak, Lawrence P Park, Christopher Woods, et al.
AIDS Research and Therapy|September 22, 2017
Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatmentEdward R Cachay, Craig Ballard, Bradford Colwell, et al.
AIDS (London, England)|September 11, 2015
Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeksPablo Tebas, Princy Kumar, Charles Hicks, et al.
Pageof 4